Transverse Medical, Inc.
Transverse Medical, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, heart valve disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2025-05-08 | NCT06962371 |